| Clinical and economic outcomes attributable to health care–associated sepsis and pneumonia MR Eber, R Laxminarayan, EN Perencevich, A Malani Archives of internal medicine 170 (4), 347-353, 2010 | 231 | 2010 |
| Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients MR Eber, M Shardell, ML Schweizer, R Laxminarayan, EN Perencevich PloS one 6 (9), e25298, 2011 | 209 | 2011 |
| Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999–2010 NP Braykov, MR Eber, EY Klein, DJ Morgan, R Laxminarayan Infection Control & Hospital Epidemiology 34 (3), 259-268, 2013 | 126 | 2013 |
| An analysis of whether higher health care spending in the United States versus Europe is ‘worth it’in the case of cancer T Philipson, M Eber, DN Lakdawalla, M Corral, R Conti, DP Goldman Health Affairs 31 (4), 667-675, 2012 | 94 | 2012 |
| The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment DC Grabowski, DN Lakdawalla, DP Goldman, M Eber, LZ Liu, ... Health affairs 31 (10), 2276-2285, 2012 | 72 | 2012 |
| The disability burden of COPD J Thornton Snider, JA Romley, KS Wong, J Zhang, M Eber, DP Goldman COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (5), 513-521, 2012 | 68 | 2012 |
| Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? ML Schweizer, MR Eber, R Laxminarayan, JP Furuno, KJ Popovich, ... Infection Control & Hospital Epidemiology 32 (2), 148-154, 2011 | 61 | 2011 |
| Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006 MS Hoffmann, MR Eber, R Laxminarayan Infection Control & Hospital Epidemiology 31 (2), 196-197, 2010 | 56 | 2010 |
| Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis. J Romley, D Goldman, M Eber, H Dastani, E Kim, S Raparla The American journal of managed care 18 (8), 460-464, 2012 | 40 | 2012 |
| Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation MP Turakhia, MD Solomon, M Jhaveri, P Davis, MR Eber, R Conrad, ... American Heart Journal 166 (3), 573-580, 2013 | 37 | 2013 |
| Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data … ML Schweizer, EN Perencevich, MR Eber, X Cai, MD Shardell, N Braykov, ... Antimicrobial Resistance and Infection Control 2, 1-6, 2013 | 16 | 2013 |
| Validity of ML Schweizer, MR Eber, R Laxminarayan ICD-9-CM, 0 | 9 | |
| Valuing COVID-19 morbidity risk reductions LA Robinson, MR Eber, JK Hammitt Journal of Benefit-Cost Analysis 13 (2), 247-268, 2022 | 8 | 2022 |
| The benefits and costs of US employer COVID‐19 vaccine mandates M Ferranna, LA Robinson, D Cadarette, MR Eber, DE Bloom Risk Analysis 43 (10), 2053-2068, 2023 | 5 | 2023 |
| The modest effects of fact boxes on cancer screening MR Eber, CR Sunstein, JK Hammitt, JM Yeh Journal of risk and uncertainty 62, 29-54, 2021 | 5 | 2021 |
| Valuing covid-19 mortality and morbidity risk reductions LA Robinson, MR Eber, JK Hammitt US Department of Health and Human Services. https://aspe. hhs. gov/reports …, 2021 | 5 | 2021 |
| Measuring the value of better diabetes management D Lakdawalla, MR Eber, FM Forma, J Sullivan, PC Michaud, LA Bradley, ... The American journal of managed care 19, E11, 2013 | 5 | 2013 |
| Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments MR Eber, DP Goldman, DN Lakdawalla, TJ Philipson, D Pritchard, ... Journal of Comparative Effectiveness Research 4 (3), 203-213, 2015 | 3 | 2015 |
| The disability burden of COPD SJ Thornton, JA Romley, KS Wong, J Zhang, M Eber, DP Goldman COPD 9, 513-521, 2012 | 3 | 2012 |
| The economic value of statin therapy T Philipson, DN Lakdawalla, D Goldman, M Eber, T Abdelgawad, ... Circulation 124 (suppl_21), A16196-A16196, 2011 | 1 | 2011 |
